Augury Capital Partners


Augury Capital has developed an investment profile in privately held pharmaceutical, biotechnology, medical device and financial service informational technology companies with the following targeted characteristics: 

 Experienced Management Teams

Mid and Late-stage Medical Device companies (lower regulatory hurdle and quicker path to revenues) and medical device service companies 

 Mid and Late-stage Service/Tool companies with unique technologies and/or services that solve fundamental issues (usually no regulatory hurdle with short-term revenue path) 

 Late-stage Biopharmaceutical companies 

 Mid and Late-stage financial services information technologies companies, particularly companies in the transaction processing sector 

 Revenue generating companies with positive cash flow or expected cash flow within 12 months

 Companies seeking expansion capital

 Companies seeking operating and execution minded  value-added investors